LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE

Guerlain S.A

LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE


Active ingredients

Octinoxate  3.00%
Titanium Dioxide  3.16%

Purpose

sunscreen

LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE Uses

  • Helps prevent sunburn

Warnings

  • For external use only.

Do not use

on damaged or broken skin.

When using this product

keep out of eyes.  Rinse with water to remove.

Stop use and ask a doctor

if rash occurs.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Shake well before use

For sunscreen use:

  • Apply liberally 15 minutes before sun exposure.
  • Reapply at least every two hours.
  • Use a water resistant sunscreen if swimming or sweating.
  • Sun protection measures.  Spending time in the sun increases your risk of skin cancer and early early skin aging.  To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
  •     Limit time in the sun, especially from 10 a.m. - 2 p.m.
  •     Wear long-sleeved shirts, pants, hats and sunglasses
  • Children under 6 months:  Ask a doctor.

Inactive ingredients

AQUA (WATER), METHYL TRIMETHICONE, DIMETHICONE, ALCOHOL, PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE, PENTYLENE GLYCOL, MICA, PHENYL TRIMETHICONE, SILICA, ACRYLATES/DIMETHICONE COPOLYMER, ALUMINUM HYDROXIDE, BUTYLENE GLYCOL DICAPRYLATE/CAPRATE, STEARIC ACID, SORBITAN SESQUIOLEATE, PHENOXYETHANOL, ALUMINA, SODIUM MYRISTOYL GLUTAMATE, HYDROXYETHYLCELLULOSE, LECITHIN, TETRASODIUM EDTA, PARFUM(FRAGRANCE), HEXYL CINNAMAL, SERICIN, HYDROXYCITRONELLAL, BHT, CITRONELLOL, ALPHA-ISOMETHYL IONONE, HYDROLYZED LINSEED EXTRACT, SORBIC ACID, [MAY CONTAIN CI 77891(TITANIUM DIOXIDE), CI 77491, CI 77492, CI 77499 (IRON OXIDES)]

LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE Other information

  • Protect this product from excessive heat and direct sun.

Question or comments?

In USA: 19 East, 57th Street, New York, NY 10022

Representative Labeling

LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE
LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE
LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE
LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE

LINGERIE DE PEAU INVISIBLE SKIN-FUSION FOUNDATION WITH SUNSCREEN BROAD SPECTRUM SPF 20 31 AMBRE PALE

OCTINOXATE, TITANIUM DIOXIDE LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:49817-0062
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 30 mg
titanium dioxide 31.6 mg

Inactive Ingredients

Ingredient Name Strength
water
METHYL TRIMETHICONE
DIMETHICONE
ALCOHOL
PENTYLENE GLYCOL
MICA
PHENYL TRIMETHICONE
SILICON DIOXIDE
aluminum hydroxide
BUTYLENE GLYCOL DICAPRYLATE/DICAPRATE
SORBITAN SESQUIOLEATE
PHENOXYETHANOL
ALUMINUM OXIDE
SODIUM MYRISTOYL GLUTAMATE
EDETATE SODIUM
.ALPHA.-HEXYLCINNAMALDEHYDE
HYDROXYCITRONELLOL
BUTYLATED HYDROXYTOLUENE
.BETA.-CITRONELLOL, (R)-
ISOMETHYL-.ALPHA.-IONONE
sorbic acid
ferric oxide red
FERRIC OXIDE YELLOW
FERROSOFERRIC OXIDE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BOTTLE
2 15 in 1 BOTTLE
3 NDC:49817-0062-3 200 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2014-04-10


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.